Cytomegalovirus Disease Terminated Phase 3 Trials for Brincidofovir (DB12151)

Back to Cytomegalovirus Disease

Also known as: Cytomegaloviral disease, unspecified / Cytomegalovirus Infections / Cytomegalovirus infection / Cytomegalovirus infection (disorder) / Cytomegalic inclusion disease / Cytomegaloviral disease / CMV infection / Cytomegaloviral infections

IndicationStatusPhase
DBCOND0042800 (Cytomegalovirus Disease)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02439970
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus DiseasePrevention
NCT02439957
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of CytomegalovirusPrevention